Depression appears to drive changes in how the body processes a specific amino acid called valine, rather than the other way ...

Depression affects about 5.8% of the Brazilian population and presents a wide range of symptoms, intensities, and durations.

A new meta-analysis shows meaningful differences among FDA-approved antipsychotic adjuncts for MDD, with lumateperone showing the strongest efficacy and aripiprazole the best overall acceptability.

Major Depressive Disorder (MDD) is far from a cookie-cutter diagnosis. Different patients report suffering from different subsets of symptoms, yet most are ultimately prescribed the same first-line ...

What social risk factors affecting your patients may affect their risk of major depressive disorder more than they realize?

The research analyzed brain scans from patients with major depressive disorder who were not taking antidepressants, isolating ...

A new study uses AI on brain scans to predict depression. The findings are modest, but the implications go beyond the ...

While they share similar depressive and cognitive symptoms, the biological underpinnings of bipolar disorder and major ...

Depression is one of the most serious health conditions affecting people today. Although many people think depression simply ...

Treatment with semaglutide significantly improves measures of motivation in patients with major depressive disorder (MDD), ...

Study identifies a specific link between insulin resistance, brain structure, and cognitive impairment in Bipolar Disorder, ...